Literature DB >> 8232068

Sensitivity of HIV antibody detection in saliva.

K Stark1, C Warnecke, V Brinkmann, H R Gelderblom, U Bienzle, G Pauli.   

Abstract

To assess the sensitivity and specificity of HIV antibody detection in saliva we tested matched serum and saliva samples from HIV-infected and uninfected individuals. Saliva specimens were collected by two different devices of the Salivette system and stored at different temperatures. Samples were tested for HIV antibodies by two commercially available enzyme-linked immunosorbent assays (ELISAs; Wellcome, Biotest). HIV antibodies were detected in 98.5% (Wellcome) and 97.8% (Biotest) of the saliva samples (standard Salivettes) from 135 seropositive individuals. Using the Salivettes flavoured with citric acid the sensitivity was only 22.9%. No reactions in ELISA were found in saliva from HIV-seronegative individuals. Salivary HIV-specific IgA was detected in 90% of seropositive individuals. All positive saliva samples stored at room temperature were still reactive after 20 days; of those stored at 37 degrees C, 23 out of 24 were positive when retested on day 5. Sensitivity of HIV antibody detection in saliva samples dried onto filter paper was 100% when a minimum of 100 microliters of saliva was used. HIV antibody testing in saliva is an efficient tool for large scale epidemiological studies when standard Salivettes are used for sample collection. Saliva samples can be stored in Salivettes or dried onto filter paper for several days at room temperature and under tropical conditions (37 degrees C).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232068     DOI: 10.1007/bf00190267

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  8 in total

1.  Detection of HIV antibodies in saliva as a tool for epidemiological studies.

Authors:  R van den Akker; J A van den Hoek; W M van den Akker; H Kooy; E Vijge; G Roosendaal; R A Coutinho; A M van Loon
Journal:  AIDS       Date:  1992-09       Impact factor: 4.177

2.  HIV excretion patterns and specific antibody responses in body fluids.

Authors:  S O'Shea; M Cordery; W Y Barrett; D D Richman; C Bradbeer; J E Banatvala
Journal:  J Med Virol       Date:  1990-08       Impact factor: 2.327

3.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-05-23       Impact factor: 17.586

4.  HIV surveillance by testing saliva.

Authors:  A M Johnson; J V Parry; S J Best; A M Smith; M de Silva; P P Mortimer
Journal:  AIDS       Date:  1988-10       Impact factor: 4.177

5.  Comparison of saliva and blood for human immunodeficiency virus prevalence testing.

Authors:  C J Major; S E Read; R A Coates; A Francis; B J McLaughlin; M Millson; F Shepherd; M Fanning; L Calzavara; D MacFadden
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

6.  Detection of specific antibodies in gingival crevicular transudate by enzyme-linked immunosorbent assay for diagnosis of human immunodeficiency virus type 1 infection.

Authors:  L E Soto-Ramírez; L Hernández-Gómez; J Sifuentes-Osornio; G Barriga-Angulo; D Duarte de Lima; M López-Portillo; G M Ruiz-Palacios
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

7.  Detection of salivary HIV-1-specific IgG antibodies in high-risk populations in Zaire.

Authors:  F M Behets; B Edidi; T C Quinn; L Atikala; K Bishagara; N Nzila; M Laga; P Piot; R W Ryder; C C Brown
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

8.  Testing of saliva for antibodies to HIV-1.

Authors:  N Crofts; S Nicholson; P Coghlan; I D Gust
Journal:  AIDS       Date:  1991-05       Impact factor: 4.177

  8 in total
  8 in total

1.  Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden.

Authors:  Workenesh Ayele; Rob Schuurman; Tsehaynesh Messele; Wendelien Dorigo-Zetsma; Yohannes Mengistu; Jaap Goudsmit; William A Paxton; Michel P de Baar; Georgios Pollakis
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

Review 2.  Detection of human immunodeficiency virus antibodies in oral fluids.

Authors:  R L Hodinka; T Nagashunmugam; D Malamud
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

3.  Increased immunoglobulin G production by short term cultured duodenal biopsy samples from HIV infected patients.

Authors:  T Schneider; T Zippel; W Schmidt; G Pauli; U Wahnschaffe; S Chakravarti; W Heise; E O Riecken; M Zeitz; R Ullrich
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

4.  Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques.

Authors:  F Schäfer; S Kewenig; N Stolte; C Stahl-Hennig; A Stallmach; F-J Kaup; M Zeitz; T Schneider
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

5.  Evaluation of two novel immunoassays designed to detect HIV antibodies in oral fluids.

Authors:  R D Saville; N T Constantine; C Holm-Hansen; C Wisnom; L DePaola; W A Falkler
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

6.  Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.

Authors:  K Stark; R Müller; U Bienzle; I Guggenmoos-Holzmann
Journal:  J Epidemiol Community Health       Date:  1996-10       Impact factor: 3.710

7.  Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya.

Authors:  C Farquhar; T VanCott; R Bosire; C Bermudez; D Mbori-Ngacha; B Lohman-Payne; R Nduati; P Otieno; G John-Stewart
Journal:  Clin Exp Immunol       Date:  2008-05-23       Impact factor: 4.330

8.  Serum and salivary IgE, IgA, and IgG4 antibodies to Dermatophagoides pteronyssinus and its major allergens, Der p1 and Der p2, in allergic and nonallergic children.

Authors:  Diego O Miranda; Deise A O Silva; Jorge F C Fernandes; Meimei G J Queirós; Hamilton F Chiba; Leandro H Ynoue; Rafael O Resende; Janethe D O Pena; Sun-Sang J Sung; Gesmar R S Segundo; Ernesto A Taketomi
Journal:  Clin Dev Immunol       Date:  2011-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.